Vogt Koyanagi Harada Disease

2

Review clinical trials related to Vogt Koyanagi Harada Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.

Participants needed: 40
Trial details
Age: 10-70Biological sex: AllType: InterventionalSponsor: University of Sao PauloUpdated: May 7, 2026Locations: 1
Eligibility criteria

non collaborative patient [+1]

Status: Recruiting

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

This project is designed to test the hypothesis that adalimumab is clinically useful for patients with acuta Vogt-Koyanagi-Harada disease

Participants needed: 15
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Tianjin Medical UniversityUpdated: Jul 3, 2024Locations: 1
Eligibility criteria

Subject is 18 to 70 years of age. [+3]

Subject with confirmed or suspected infectious uveitis, including but not limite... [+5]